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It is fundamentally important that signaling gradients
provide positional information to governmorphogen-
esis of multicellular organisms. Morphogen gradi-
ents can generate different cell types in specific
spatial order at distinct threshold concentrations.
However, it is largely unknown whether and how
signaling gradients also control cell polarities by
acting as global cues. Here, we show that Wnt
signaling gradient provides directional information
to a field of cells. Vangl2, a core component in planar
cell polarity, forms Wnt-induced receptor complex
with Ror2 to sense Wnt dosages. Wnts dose-depen-
dently induce Vangl2 phosphorylation of serine/thre-
onine residues and Vangl2 activities depend on its
levels of phosphorylation. In the limb bud, Wnt5a
signaling gradient controls limb elongation by
establishing PCP in chondrocytes along the prox-
imal-distal axis through regulating Vangl2 phosphor-
ylation. Our studies have provided new insight to
Robinow syndrome, Brachydactyly Type B1, and
spinal bifida which are caused by mutations in
human ROR2, WNT5A, or VANGL.
INTRODUCTION
Multicellular organisms control their morphogenesis by forming
signaling gradients to coordinate growth and patterning (Law-
rence, 2001; Turing, 1952; Wolpert, 1969), during which estab-
lishment of polarity in a field of cells is essential. Wnts are a class
of secreted ligands that can transduce their signals through
several distinct pathways to regulate a diverse array of develop-
mental processes (Angers and Moon, 2009; Logan and Nusse,
2004). A critical function of Wnt signaling in vertebrates is to
regulate planar cell polarity (PCP) (Heisenberg et al., 2000;
Qian et al., 2007; Rauch et al., 1997). PCP, which originally refers
to the polarity of epithelial cells within a plane orthogonal to their
apical-basal axis, is well characterized genetically in Drosophila
melanogaster and is regulated by a group of evolutionarilyDevelopmconserved core PCP components including a four-pass trans-
membrane protein, Van Gogh (Vang) (McNeill, 2010; Seifert
and Mlodzik, 2007; Tree et al., 2002; Wang and Nathans, 2007;
Zallen, 2007). Its vertebrate homologs are Vang like 1 and 2
(Vangl1 and Vangl2) (Jessen and Solnica-Krezel, 2004; Kibar
et al., 2001; Murdoch et al., 2001; Song et al., 2010; Torban
et al., 2007). However, a long-range positional cue that globally
coordinates PCP and creates the initial polarity required for
asymmetrical cellular behaviors in vertebrate development
remains to be identified (Lawrence et al., 2007; Strutt, 2009).
In mammals, PCP has emerged as a fundamental regulatory
mechanism controlling many critical developmental processes
(Borovina et al., 2010; Guirao et al., 2010; Hashimoto et al.,
2010; McNeill, 2010; Song et al., 2010; Torban et al., 2008).
For instance in humans, disrupted convergent extension (CE)
movement, a process regulated by PCP (Heisenberg et al.,
2000; Jessen et al., 2002), results in failure of neural tube closure,
which causes the condition of spina bifida, a common perma-
nently disabling birth defect. Mutations in VANGL1 have been
identified in spina bifida patients (Kibar et al., 2007). In addition,
mutations in VANGL2 led to stillborn fetuses with various neural
tube defects (Lei et al., 2010). However, despite the critical roles
of PCP and Wnt signaling in vertebrate development, surpris-
ingly little is known about the mechanism underlying PCP regu-
lated by Wnt signaling in vivo.
SomeWnts, likeWnt5a, transduce their signalsmainly through
the b-catenin-independent noncanonical pathways in vivo
(Topol et al., 2003; Westfall et al., 2003) and Wnt5a genetically
interact with Vangl2 (Qian et al., 2007), suggesting that Wnt5a
may regulate PCP. Wnt5a has also been suggested to signal
through Ror2, a single pass transmembrane protein with a tyro-
sine kinase domain, which binds Wnt5a through its extracellular
cysteine-richWnt binding domain (CRD) (Oishi et al., 2003). Ror2
mediates Wnt5a signal to inhibit the b-catenin-dependent
canonical Wnt signaling activity and activate c-Jun N-terminal
kinase (JNK) in vitro (Mikels and Nusse, 2006; Oishi et al.,
2003). Because mutations in human ROR2 and WNT5A lead to
Robinow syndrome and/or BDB1 (Afzal et al., 2000; Person
et al., 2010; Schwabe et al., 2000; van Bokhoven et al., 2000)
and mouse Wnt5a and Ror2 mutant embryos bear many similar
phenotypes (DeChiara et al., 2000; Oishi et al., 2003; Takeuchi
et al., 2000; Yamaguchi et al., 1999; Yang et al., 2003), Ror2
may mediate Wnt5a signaling in vivo. However, the mechanismsental Cell 20, 163–176, February 15, 2011 ª2011 Elsevier Inc. 163
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types of Robinow syndrome and BDB1 remain elusive.
Here, we have found that Ror2 and Vangl2 form aWnt-induced
receptor complex that is essential to establish PCP, hence direc-
tional growth, by interpreting Wnt dosage gradients. Wnts
including Wnt5a induced Vangl2 phosphorylation on two clus-
ters of serine (S) and threonine (T) residues in a Wnt5a dose-
dependent manner both in vitro and in vivo. Wnt5a-induced
Vangl2 phosphorylation was essential for its function. More
highly phosphorylated Vangl2 was more active. Our data
suggest that by translatingWnt5a gradients into a Vangl2 activity
gradient, chondrocytes are polarized along the proximal-distal
(P-D) axis and such polarization is required for P-D limb
elongation.
RESULTS
Ror2 and Vangl2 Act Together to Transduce the Wnt5a
Signal
The mouseWnt5a/ and Ror2/ exhibited similar phenotypes
of shortened anterior-posterior (A-P) body axis to that of the Lp
(Vangl2Lp/+) mutants that was caused by a dominant negative
allele of Vangl2 (DeChiara et al., 2000; Kibar et al., 2001; Song
et al., 2010; Takeuchi et al., 2000; Yamaguchi et al., 1999), sug-
gesting that Ror2 may act in the Wnt5a pathway to control PCP
during CE. In addition, the Wnt5a/, Ror2/ and Vangl2Lp/Lp
mutants showed shortened limbs along the P-D axis (Figure 1A).
These observations suggested that limb elongation along the P-
D axis may be regulated by Wnt5a and Ror2 in a process similar
to CE and requiring PCP. To test these hypotheses, we first
examined Ror2 expression patterns in mouse embryos. Using
a LacZ ‘‘knockin’’ allele of Ror2 (DeChiara et al., 2000), we found
that Ror2 was broadly expressed and its expression overlapped
with that ofWnt5a and Vangl2 temporally and spatially (Yamagu-
chi et al., 1999)(see Figure S1A available online). However, the
phenotypes of Ror2/ and even Ror1/; Ror2/ mutants
(Nomi et al., 2001) were less severe than those of the Wnt5a/
mutants, but theWnt5a/; Ror2/ andWnt5a/ mutants dis-
played identical phenotypes (Figure S1B). Thus, the Ror family
members only mediate part of Wnt5a signaling in vivo.
Since a major driving force of limb elongation along the P-D
axis is the directional growth of the long bone cartilage, we
tested whether reduced P-D elongation of the limb in the
Wnt5a/ and Ror2/mutants is due to disrupted PCP in chon-
drocytes of the limb (Figure 1B). The wild-type chondrocytes
were flattened and stacked in columns along the P-D axis.
Such organization of chondrocytes in theWnt5a/ and Ror2/
embryos was altered substantially and looked similar to those in
the Vangl2Lp/Lp limb bud (Figures 1B and 1C; Figures S1C and
S1D). Thus, chondrocytes are likely to be polarized along the
P-D axis and Vangl2 may mediate Wnt5a signal together with
Ror2 in regulating such polarity. This hypothesis predicts that
the Ror2 mutant should genetically interact with the Vangl2Lp/+
mutant. Indeed, the Ror2/; Vangl2Lp/+ mice exhibited open
neural tube and disrupted hair cell polarity in the sensory epithe-
lium of the cochlea, which are typical PCP defects in mammals
that rarely occurred in either Ror2/ or Vangl2Lp/+ mutants
(Figure 1D; Figures S1E and S1F) (Qian et al., 2007). Using
a Vangl2- allele (previously referred to as the Vangl2D allele) we164 Developmental Cell 20, 163–176, February 15, 2011 ª2011 Elsevhave generated (Song et al., 2010), strong genetic interactions
of Ror2 and Vangl2 were also observed in the developing carti-
lage of the limb (Figure S1G). Thus, Ror2, likeWnt5a, also regu-
lates PCP in mammalian embryonic development including limb
elongation. These results led us to hypothesize thatWnt5a signal
is transduced by both Ror2 and Vangl2. Indeed, we found that
Wnt5a/ andRor2/; Vangl2/ embryos showed almost iden-
tical phenotypes in places like the limb, tail, and frontonasal
processes (Figure 1E). In the forelimb, distal digits failed to
form (Figure 1F).
In addition to the morphological defects, we found that
expression of Sox9, the earliest known marker for cartilage
formation (Bi et al., 1999), was not detected in the Ror2/;
Vangl2/ distal limb buds, similar to what was observed in the
Wnt5a/ embryos (Topol et al., 2003) (Figure 2A). As in the distal
limb of theWnt5a/ embryos, antichondrogenic Wnt/b-catenin
signaling was also upregulated in the distal limb of the Ror2/;
Vangl2/ mutant, but not the Ror2/ or Vangl2/ mutant at
E13.5 (Figure 2B; Figure S2A). Upregulated Wnt/b-catenin
signaling in the wild-type limb mesenchyme was observed
around the forming joint which expressed Gdf5 (Figure 2B; Fig-
ure S2B), but in the Ror2/; Vangl2/ mutant limb, there was
no ectopic joint formation shown by lack of ectopicGdf5 expres-
sion in the distal limb (Figure S2B). Thus, ectopic upregulation of
Wnt/b-catenin signaling in the Ror2/; Vangl2/ mutant was
not caused by abnormal cell fate change. Consistent with this,
Wnt5a inhibition of the Wnt/b-catenin signaling was abolished
in the Ror2/ mouse embryonic fibroblast (MEF) cells, but in
the Ror2/; Vangl2/ MEF cells, Wnt5a further increased
Wnt/b-catenin signaling stimulated by Wnt3a (Figure 2C). Loss
of both Ror2 and Vangl2 may have allowed uncovering Wnt5a’s
activity to signal through the canonical Wnt pathway. Wnt5a-
induced cell migration was also more severely impaired in the
Ror2/; Vangl2/MEF cells (Figure S2C). As previous findings
have indicated that non-canonical Wnt signaling regulates JNK
and Rho activation (Kikuchi et al., 2009; Yamamoto et al.,
2008), we have examined JNK and Rho activation and found
that loss of Ror2 and Vangl2 led to reduced induction of c-Jun
phosphorylation and Rho activation in MEF cells (Figures S2D
and S2E). Together, these analyses indicate that Ror2 and
Vangl2 act together to transduce multiple aspects of noncanon-
ical Wnt signaling in embryonic development.
Wnt5a Induces Ror2 and Vangl2 Complex Formation
We next tested whether Ror2 and Vangl2 form a receptor
complex to transduce Wnt signal as Ror2 binds Wnt5A (Oishi
et al., 2003). Both Ror2 and Vangl2 were distributed randomly
on the cell membrane of limb bud mesenchymal cells before
E11.5 and strikingly, when chondrocytes form in an E12.5 distal
limb, asymmetrical localization of Vangl2 protein along the P-D
axis of the limb was observed in chondrocytes, not in the non-
chondrocyte mesenchymal cells in the limb (Figure 3A; Fig-
ure S3A), demonstrating that chondrocytes in the developing
cartilage of the limb are indeed polarized and oriented along
the P-D axis. Consistent with this, Ror2 expression is selectively
upregulated in the forming cartilage (Figure S1A; DeChiara et al.,
2000). Closer examination of Vangl2 staining showed that it was
localized to the proximal side of chondrocytes (Figure S3B), but it
did not colocalize with cilia (Figure S3C). Ror2 and Vangl2 wereier Inc.
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ure S3D), but no asymmetrical Ror2 protein localization was
observed (Figure 3A).
Importantly, Wnt ligands including Wnt5a strongly induced
Ror2 and Vangl2 complex formation (Figure 3B; Figure S3E). In
the Wnt5a/ limb, Ror2-Vangl2 complex formation was
reduced (Figure S3D). To test whether Ror2 and Vangl2 interact
directly in the Wnt5a receptor complex, we performed YFP/CFP
Fluorescence Resonance Energy Transfer (FRET) analysis and
found that Ror2 and Vangl2 were localized in close proximity
on the plasma membrane. Such interaction was significantly
more stable in the presence of Wnt5a (Figure 3C). A Lp mutant
Vangl2 protein (S464N) that is trapped in the ER (Merte et al.,
2010) failed to form a complex with Ror2, even in the presence
of Wnt5a (Figure 3D), suggesting that Ror2-Vangl2 complex
formation occurs on the plasma membrane and is required for
Wnt5a signal transduction.
To test whether Wnt5a-induced Ror2-Vangl2 complex forma-
tion is a prerequisite for asymmetrical Vangl2 localization, a func-
tional readout of PCP, Vangl2 protein localization was examined
in different mutants (Figure 4A; Figure S4A). In the Wnt5a/
mutant or the Vangl2Lp/Lp mutant where Vangl2 protein failed
to reach the membrane and form a complex with Ror2 in vitro,
Vangl2 asymmetrical localization was lost in chondrocytes (Fig-
ure 4A; Figure S4A). In the Ror2/ limb, Vangl2 asymmetrical
localization was reduced in chondrocytes of the distal limb (Fig-
ure 4A), but in more mature chondrocytes of the more proximal
limb, Vangl2 asymmetrical localization was lost (Figure S4A).
These results suggest that weakened Wnt signaling in the
Ror2/ limb chondrocytes failed to establish Vangl2 asymmet-
rical localization in the proximal limb. Because Wnt5a is ex-
pressed in a gradient along the P-D axis of the limb (Figure S4B),
we examined whether there was a gradient of Vangl2 asymmet-
rical localization. We found that the relative number of cells
showing Vangl2 asymmetrical localization was reduced progres-
sively along the P-D axis (Figure 4B), demonstrating that there is
a correlation between Wnt5a signaling strength and the level of
Vangl2 asymmetrical localization. Indeed in the Ror2/ limb,
Vangl2 asymmetrical localization declined rapidly along the
P-D axis (Figure 4B). Considering that all of Wnt5a/, Ror2/,
and Vangl2Lp/Lp mutants exhibited loss of Vangl2 asymmetrical
localization and shorter and broader long bone cartilages (Fig-
ure 1A; Figure S4C), PCP in chondrocytes plays an essential
role to control directional cartilage growth in the limb. Failure
to transduce the Wnt5a signal together with Ror2 is responsible
for the limb phenotypes of the Vangl2Lp/Lp mutant. Taken
together, these data indicate that Wnt5a modulates the canon-
ical Wnt signaling activity and controls PCP by inducing Ror2-
Vangl2 complex formation.
Wnts Act Through Ror2 to Induce Vangl2
Phosphorylation
To investigate the molecular mechanism whereby Wnt signal
controls PCP through the Ror2-Vangl2 receptor complex, we
tested whether Wnts regulate Vangl2 activity by inducing its
posttranslational modification.We found that some of the Vangl2
protein showed retarded gel mobility by the SDS-PAGE analysis
(Figure 5A). Since such protein mobility shift was completely
abolished by treating the samples with calf intestinal phospha-Developmtase (CIP), Vangl2 protein was phosphorylated. Interestingly,
Vangl2 phosphorylation was enhanced by overexpression of
many Wnts, Ror2, and most strongly by coexpression of Wnts
andRor2 (Figure 5B).Wnt5a has the strongest effects in inducing
Vangl2 phosphorylation (Figure 5B; Figure S5A), consistent with
its prominent role in controlling PCP inmammalian development.
Thus, we focused on Wnt5a in the rest of the study. Vangl2
phosphorylation appears to be an early event of Wnt5a signaling
as Wnt5a-induced Vangl2 phosphorylation was detected by 1 hr
after Wnt5a treatment (Figure S5B). Wnt5a has been shown to
bind Ror2 and in the Ror2/ MEF cells, Wnt5a-induced
Vangl2 phosphorylation was greatly diminished (Figure 5C),
indicating that Wnt5a acts through Ror2 to regulate Vangl2
phosphorylation.
The diffuse pattern of Vangl2 protein mobility shift indicates
that there are multiple forms of phosphorylated Vangl2 and
Vangl2 can be hyperphosphorylated on many different sites.
To identify these Vangl2 phosphorylation sites, we compared
protein sequences of Vangl1 and Vangl2 from multiple inverte-
brate and vertebrate species and found that there are two clus-
ters of highly conserved S and T residues located in the
N-terminal cytoplasmic domain (Figure 5D; Figure S5C).
Mutating these S and T residues to alanine (A) individually or in
combination reduced basal level and Wnt5a-induced Vangl2
phosphorylation (Figures 5E–5G; Figure S5D). Interestingly, in
both Cluster I and II, the contribution of each S or T to Vangl2
phosphorylation differs depending on its location in the cluster.
In Cluster I, when mutated individually, S84A, followed by the
S82A, has the strongest impact on reducing basal level Vangl2
phosphorylation. The S84A mutation almost completely abol-
ished Vangl2 basal level phosphorylation. When mutated in
combination, S84A and S82A together most severely reduced
basal level and Wnt5a-induced Vangl2 phosphorylation (Fig-
ure 5E). The two triple mutation combinations of T76A-T78A-
S79A and T71A-T72A-T73A had progressively weaker impact
on basal level and Wnt5a-induced Vangl2 phosphorylation and
both of these combinations had weaker effect than S84A (Fig-
ure 5E). These results indicate that phosphorylation in Cluster I
occurs in a relay fashion starting from the C terminus and
suggest that phosphorylation on the two C-terminal sites (S84
and S82) is required for phosphorylation of the more N-terminal
sites in the direction of S79 to T71. However, S82A and S84A
mutations did not completely abolish Wnt5a-induced Vangl2
phosphorylation (Figure 5E), suggesting that Wnt5a also induces
Vangl2 phosphorylation outside of Cluster I. Indeed, mutating
the S residues in Cluster II led to significantly reduced basal level
and Wnt5a-induced Vangl2 phosphorylation, too (Figure 5F).
Furthermore, mutating S sites closer to the N terminus of cluster
II resulted in progressively more severe reduction of Wn5a-
induced Vangl2 phosphorylation (Figure 5F), indicating that
phosphorylation in cluster II also occurs in a relay fashion, but
starting from the N terminus and suggest that phosphorylating
the N-terminal site (S5A) is required to phosphorylate the more
C-terminal sites in the direction from S5 to S20.
To further test the effects of S84, S82 and S5 as founder sites
for Vangl2 phosphorylation, we mutated S517 and all of the
Cluster I S/T sites and found this resulted in similarly reduced
Vangl2 phosphorylation when only S5 and Cluster I sites were
mutated, indicating S5 is indeed a founder site for Cluster IIental Cell 20, 163–176, February 15, 2011 ª2011 Elsevier Inc. 165
Figure 1. Ror2 and Vangl2 Mediate Wnt5a Signaling in Embryonic Development
(A) The limb length from the elbow to the distal tip is indicated by a line and quantified in the right column (two-tail t test, all *p values < 0.01). Error bars are ± SD,
n = 3.
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Figure 2. Ror2 and Vangl2 Together Mediate Wnt5a Inhibition of the Wnt/b-Catenin Signaling
(A) Sox9 expression detected by whole mount in situ hybridization. Arrows indicate lack of chondrocyte differentiation in the distal limb mesenchymal cells of the
Ror2/; Vangl2/ and Wnt5a/ embryos.
(B) X-gal staining of limb buds showed endogenous staining in the joint (black arrows) and ectopic staining in the distal limb of the Ror2/; Vangl2/; TopGal
embryo (red arrows).
(C) The Wnt/b-catenin signaling activity was measured by the TOPFLASH luciferase assay in MEF cells. The ability of Wnt5a to inhibit Wnt3a-induced Wnt/
b-catenin activity in wild-type MEFs (two-tail t test *p = 0.0013) is impaired in the Ror2/ and Ror2/; Vangl2/ MEFs (two-tail t test, *p = 0.0015). Error
bars are ± SD, n = 3. The control and Wnt3a conditioned medium was mixed with that of Wnt5a at a 1:1 ratio.
See also Figure S2.
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S82, S84 had similar effects as mutating S517 and all Cluster I
sites (Figure 5G). Furthermore, mutating all of the three founder
sites, but not any two of them (S84+S5, S82+S5 or S82+S84)
completely abolished basal level and Wnt5a-induced Vangl2
phosphorylation just like mutating all Cluster I and II sites (Fig-
ures 5E and 5G; Figure S5D). Thus, phosphorylation of S84,
S82, and S5 is required for phosphorylating other sites in Cluster
I and Cluster II, respectively. S84 and S82 act together as
founder sites for cluster I phosphorylation. These results further
demonstrate that Wnt5a-induced Vangl2 phosphorylation
mostly occurred on the S and T residues of Cluster I and II.
Indeed, basal level orWnt5a-induced Vangl2 tyrosine (Tyr) phos-
phorylation was not detected and a kinase-dead Ror2 mutant
(Hikasa et al., 2002) still retained the ability to enhance Wnt5a-
induced Vangl2 phosphorylation (Figure 6B; Figures S5E–S5G).
As a first attempt to further understand the regulation of
Vangl2 phosphorylation, we set out to identify the kinase(s)
that phosphorylates Vangl2. In Drosophila, Casein Kinase 1
(CKI) (Klein et al., 2006; Strutt et al., 2006) has been shown to
be a mandatory factor in the PCP pathway. We tested whether(B) Sections of distal limbs showing chondrocyte organization in the newly forme
chondrocyte extracellular matrix; DAPI (blue) stains the nucleus.
(C) Statistical analysis of length-to-width ratio of chondrocytes shown in Figure 1B
width.
(D) Neural tube was open (red arrows) in > 50% of the Ror2/; Vangl2Lp/+ embr
(E) The Ror2/; Vangl2/ and theWnt5a/ embryos exhibited identical pheno
and tails (arrowheads). The limb was enlarged in the lower panel.
(F) Skeletal preparations stained by alcian blue and alizarin red of forelimbs.
See also Figure S1.
DevelopmCKI is also involved in regulating Vangl2 phosphorylation. In
CHO cells, overexpression of CKId, but not CKI3 promoted
Vangl2 phosphorylation. Conversely, treatment by D4476,
a pharmacological inhibitor of CKI (Rena et al., 2004), inhibited
Vangl2 phosphorylation induced byWnt5a and Ror2 (Figure 5H),
suggesting that CKId is required to phosphorylate Vangl2 in
response to Wnt5a.
Vangl2 Activities Are Regulated by Its Phosphorylation
To test the functional significance of Vangl2 phosphorylation, we
noticed that one of human VANGL1 mutation S83L identified in
spinal dysraphisms is equivalent to the mouse Vangl2 S79 (Kibar
et al., 2009) which is in Vangl2 phosphorylation cluster I. In addi-
tion, a mutation of a phosphorylation founder site in cluster I of
human VANGL2, S84F, has been found in stillborn fetuses (Lei
et al., 2010), suggesting that Vangl2 phosphorylation is required
for its function in vivo. In agreement with this, we found that the
WNT5A mutations (C83S and C182R) associated with the domi-
nant form of Robinow syndrome (Person et al., 2010) had weak-
ened ability to induce Vangl2 phosphorylation (Figure 6A).
Furthermore, we found that Ror2 mutations identified in thed cartilage (schematized in the right panel). Wheat germ agglutinin (red) stains
(two-tail t test, all *p values < 0.01). Error bars are ± SD, n > 100. L, length; W,
yos.
types of loss of distal digits (circles), shortened frontonasal processes (arrows)
ental Cell 20, 163–176, February 15, 2011 ª2011 Elsevier Inc. 167
Figure 3. Wnt5a Induces Ror2 and Vangl2 Complex Formation
(A) Fluorescent immunohistochemistry of Ror2 (red) and Vangl2 (green) (viewed by projected Z-stack) showing asymmetrical Vangl2 localization at E12.5 (arrows),
not E11.5. Selected limb fields are schematized in the right panel.
(B) Co-IP of Ror2 and Vangl2 in HEK293T cells. Wnt5a strongly increased their interaction.
(C) MDCK cells expressing YFP-Vangl2 and Ror2-CFP were assayed for fluorescence resonance energy transfer efficiency (N-FRET) with (0.13 SD ± 0.02) or
without Wnt5a (0.11 SD ± 0.05), Kolmogorov-Smirnov two-sample test (two-tail): p = 0.029.
(D) A Loop-tail mutant Vangl2Lp (S464N) protein failed to form complex with Ror2 in HEK293T cells, even in the presence of Wnt5a.
See also Figure S3.
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exhibited reduced activity in promoting Vangl2 phosphorylation
comparedwith thewild-typeRor2 inRor2/MEF cells, whereas
the kinase dead mutant of Ror2 showed similar activity as the
wild-type control (Figure 6B). These results suggest that reduc-
tion of VANGL2 phosphorylation impairs its function and
reduced VANGL2 activity due to abnormal WNT5A/ROR2
signaling is an important mechanism underlying Robinow
syndrome and BDB1.
The functional significance of Vangl2 phosphorylation was
also supported by the two Lp mutations (D255E and S464N)
which caused Vangl2 protein to be trapped in the ER and fail
to form complex with Ror2. Both basal level and Wnt5a-induced
Vangl2 phosphorylation was completely abolished by the Lp
mutations, but not the S464A mutation (Figure 6C). Furthermore,
we raised antibodies recognizing phospho-Vangl2 to detect
Vangl2 phosphorylation in vivo (Figures S6A–S6C). The Vangl2
protein levels and phosphorylation were both drastically reduced
in a Lp mutant mouse strain (S464N) (Figure 6D), supporting
that Vangl2 phosphorylation is regulated by Wnt5a/Ror2
signaling at the plasma membrane. Interestingly, when coex-
pressed with the S464N mutant, phosphorylation of wild-type168 Developmental Cell 20, 163–176, February 15, 2011 ª2011 ElsevVangl2 was also reduced (Figure 6E), providing molecular
evidence that the Lp mutation is dominant negative. These
results suggest that loss of Vangl2 phosphorylation due to
Vangl2 ER trapping underlies the developmental abnormalities
of the Vangl2Lp/+ and Vangl2Lp/Lp embryos asWnt/PCP signaling
is severely impaired in the mutants.
To directly test whether Vangl2 phosphorylation is required for
its function, we first examined activation of c-Jun N-terminal
kinases (JNK) and Rho by Vangl2 (Figure S6D). The Vangl2
mutant that could not be phosphorylated exhibited diminished
activity in activating JNK or Rho. Furthermore, we took advan-
tage of the zebrafish trilobite (tri) mutant caused by a null muta-
tion of Vangl2 (trim209/m209)(Jessen et al., 2002) and tested the
function of Vangl2 variants by comparing their rescuing effi-
ciency (Figure 6F). While injecting the control GFP mRNA did
not perturb the phenotypes (Figure S6Ea), injecting the wild-
type mouse Vangl2 mRNA to the wild-type or heterozygous
(trim209/+) fish led to CE defects as PCP signaling is dose sensi-
tive and both loss and gain of function PCPmutants show similar
phenotypes (Figures 6Ga, 6Gd, and S6Eb). Therefore, different
doses of wild-type and mutant Vangl2mRNA were injected (Fig-
ure 6G; Figure S6E). Importantly, 60pg wild-type mouse Vangl2ier Inc.
Figure 4. Wnt5a Is Required for Vangl2
Asymmetrical Localization
(A) Digit chondrocytes of E12.5 embryos is shown
by Sox9 expression (red) (upper panel). The
selected regions (boxed) are enlarged and shown
with Vangl2 (green) and b-catenin (red) co-stain-
ing (projected Z-stacks) (middle panel). The
boxed regions are shown in lower panel with
separate staining of Vangl2 and b-catenin. Vangl2
asymmetrical localization (arrow) is completely
lost in the Wnt5a/ limb. In the Ror2/ mutant
limb, Vangl2 asymmetrical localization was lost
in the more mature cartilage (see Figure S4A),
but still detectable in the distal limb bud with
reduced intensity (arrow). Vangl2 is still localized
to the cell membrane inWnt5a/mutants (arrow-
head). D, distal; P, proximal.
(B) Projected Z-stack pictures of Vangl2 staining
(green) from distal (D), middle (M) or proximal (P)
parts of E12.5 wild-type or Ror2/ embryonic
distal limbs (schematized in left panel). The
number of cells with Vangl2 asymmetrical locali-
zation is progressively reduced from distal to
proximal parts and much reduced in the Ror2/
mutant. Quantified results were shown in lower
panel.
Error bars are ± SD, n = 2. See also Figure S4.
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Wnt Controls PCP by Inducing Vangl PhosphorylationmRNA rescued the CE defects in about 95% of the injected
trim209/m209 fish embryos (Figure 6Ga). Higher or lower dosages
of wild-type mouse Vangl2 mRNA both reduced its recuing effi-
ciency (Figure 6Gd; Figure S6Eb). However, while the mouse
S84A Vangl2 mRNA was more potent in causing CE defects in
the wild-type and trim209/+ embryos, it was much less efficient
in rescuing the CE defects of the trim209/m209 fish at all doses
tested (Figures 6Gb and 6Ge; Figure S6Ec). Furthermore,
the most severe Vangl2 phospho mutant (S517A::S7684A)
almost completely lost its ability to rescue the trim209/m209 embryo
at all doses tested (Figures 6Gc and 6Gf; Figure S6Ed). We have
also generated phosphomimickingmutant of Vangl2 bymutating
S5, 82, and 84 to glutamate (E). The phosphomimicking mutantDevelopmental Cell 20, 163–176, Fof Vangl2 exhibited higher rescuing effi-
ciency at a lower dosage compared with
the wild-type control (Figure 6Gg versus
6Ga and 6Gd) and slightly increasing the
dose of phosphomimicking mutant of
Vangl2 quickly reduces its rescuing effi-
ciency (Figure S6Ee), indicating that the
phosphomimicking mutant of Vangl2 is
an activated form of Vangl2. We then
tested whether differential rescuing abili-
ties of the Vangl2mutants are caused by
the difference in protein stability or
membrane localization. We examined
the protein made from the injected
Vangl2 mRNAs. The stability of the all
phospho mutant S517A::S7684A
was reduced, but the stability of the
S84A mutant was normal although it had
reduced activity (Figure 6H). In addition,the phosphomimickingmutant S5,82,84E had increased activity,
which did not correlate with increased protein stability
(Figure 6H). Furthermore, the S84A mutant showed comparable
membrane localization to the wild-type Vangl2 protein and the
all phospho mutant was also found on the membrane, although
less efficiently (Figure S6F). These results demonstrate that
Vangl2 phosphorylation is required for its function and higher
levels of phosphorylation result in more active Vangl2.
Wnt5a Gradient Establishes PCP by Inducing Distinct
Levels of Vangl2 Phosphorylation
As Wnt5a forms a dosage gradient in many places in the mouse
embryo including the limb (Figure S4B) andWnt5a is required forebruary 15, 2011 ª2011 Elsevier Inc. 169
Figure 5. Wnts Act through Ror2 to Induce Vangl2 Phosphorylation
(A) Mobility shift of Vangl2 expressed in CHO cells on SDS-PAGE gel was enhanced byWnt5a, but abolished after treatment with calf intestine phosphatase (CIP).
(B) CHO cells were transfected to express different mouseWnts, Ror2 and Vangl2 in the indicated combination. Vangl2 phosphorylation was analyzed by immu-
noblot. Arrows indicate hyperphosphorylated (upper), hypophosphorylated (middle) and unphosphorylated (lower) Vangl2 forms.
(C) MEF cells were treated with recombinant Wnt5a protein for 2 hr and Vangl2 phosphorylation was analyzed.
(D) Mouse Vangl2 with two phosphorylation clusters. Founder sites of Cluster I and II are underlined and shown in bold. Mutant Vangl2 with various serine/
threonine (S/T) to alanine (A) variants are shown.
(E) S84 and S82 are founder sites for Cluster I phosphorylation. Phosphorylation of Cluster II sites still occurred when all Cluster I sites were mutated.
(F) S sites in Cluster II of Vangl2 were individually mutated to A. Wnt5a-induced Vangl2 phosphorylation was progressively more reduced from S20A to S5A.
(G) Mutating all three founder sites, S5, 82, 84, is sufficient to completely abolish both basal level and Wnt5a-induced Vangl2 phosphorylation in CHO cells.
(H) Vangl2 phosphorylation is induced by CK1d not CK13 and partially blocked by CKI inhibitor D4476 (100 mM) in CHO cells.
See also Figure S5.
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Wnt Controls PCP by Inducing Vangl PhosphorylationPCP (Figures 1 and 4), we tested whether Wnt5a dosage
gradient acts as a global cue to establish PCP by controlling
Vangl2 activity through phosphorylation. We first examined
Vangl2 phosphorylation in the developing embryo and found
that Vangl2 protein from the brain and limb was hyperphos-
phorylated (Figure S6B). We then tested whether Wnt5a dosage
gradient is sensed in responding cells by inducing distinct levels170 Developmental Cell 20, 163–176, February 15, 2011 ª2011 Elsevof Vangl2 phosphorylation. We divided the E11.5 limb bud into
three zones along the P-D axis and a gradient of Vangl2 phos-
phorylation was found (Figure 7A). The distal cells were most
highly phosphorylated. When the frontonasal processes were
divided into distal (high Wnt5a expression) and proximal parts
(lowerWnt5a expression), we also found that Vangl2 was hyper-
phosphorylated in the distal parts (Figure S7A). In the Ror2/ier Inc.
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Wnt Controls PCP by Inducing Vangl PhosphorylationandWnt5a/ distal limb bud, hyperphosphorylated Vangl2 was
reduced (Figure 7B). In theWnt5a/ mutant, Vangl2 phosphor-
ylation levels in the distal limb were reduced to those similar to
the proximal limb bud (Figure S7B), indicating that Vangl2 phos-
phorylation gradient in the limb bud is regulated by Wnt5a
through Ror2. However, when phosphorylation at the S84 and
S82 sites were examined by phospho-specific antibodies, there
was no difference between wild-type control and the Wnt5a or
Ror2 mutants (Figure 7B), suggesting that priming at the S84
and S82 may not require Wnt5a signaling. To further test that
different levels of Vangl2 phosphorylation are induced by distinct
dosages of Wnt5a, we cocultured cells expressing Vangl2 and
Ror2 with various numbers of Wnt5a-expressing cells or
increasing concentrations of Wnt5a recombinant protein
(Figures 7C and 7D). Indeed, increasing Wnt5a dosages led to
progressively more extensive Vangl2 phosphorylation. We then
tested whether changing the Wnt5a gradient would alter Vangl2
asymmetrical localization. We grafted chick embryonic fibro-
blast (CEF) cell pellets that have been infected with the RCAS-
Wnt5a virus to the chick limb bud (Figure S7C). Because the
RCAS-Wnt5a virus produced in the CEF cell pellets can infect
neighboring tissues, 3 days after grafting, most of the limb had
already been infected by the virus, hence expressedWnt5a (Fig-
ure 7C). As a result of this widespread expression of Wnt5a,
unidirectional and asymmetrical Vangl2 localization was disrup-
ted (Figure S7C). Taken together, these data indicate that Wnt5a
forms a signaling gradient that controls PCP and embryonic
morphogenesis by inducing distinct levels of Vangl2
phosphorylation.
DISCUSSION
Although fundamental in development, the molecular mecha-
nism by which directional cellular and tissue behaviors are
controlled is still poorly understood. For instance, it is an
outstanding question in limb development what controls direc-
tional limboutgrowth along theP-Daxis. HereweshowbyVangl2
asymmetrical localization that chondrocytes of the developing
mouse limb are indeed polarized along the P-D axis and such
polarization is required for the P-D elongation of the long bone
cartilage. A key controlling event in establishing PCP is a global
directional cue that orients a field of cells. However, the nature
and identity of this global cue in vertebrates are not clear. In
Drosophila, Wnts have not been found to control PCP. Here in
the mouse developing limb, our in vivo and in vitro studies indi-
cate that a Wnt5a signaling gradient provides directional cues
to a field of cells by controlling distinct levels of Vangl2 phosphor-
ylation, henceVangl2 activities, in these cells (Figures 7E and 7F).
Secreted signaling molecules like Wnts are fundamentally
important in development by acting as morphogens in a field
of initially homogeneous cells to produce specific cellular
responses determined by morphogen concentration. The nature
of the cellular response and the molecular mechanisms under-
lying dosage sensing and interpretation in responding cells lie
at the center of our understanding of morphogen function.
Despite the important roles Wnts play in many developmental
processes, it was not clear until now that Wnt gradients also
regulate morphogenesis by controlling cell polarity. In this re-
gard, Wnts control PCP in a field of cells by inducing distinctDevelopmlevels of Vangl2 phosphorylation at varying dosages through
Ror2 (Figures 7E and 7F). It is conceivable that Wnt morphogen
gradients do not just regulate cell fate specification, but also
coordinate cell proliferation and differentiation with cell polarity
establishment. Here, we show that a Wnt protein gradient in
a field of cells is translated into a Vangl2 activity gradient, which
in turn establishes unidirectional PCP (Figure 7F). When estab-
lishing PCP, a cell senses an initial small difference in Vangl2
activity in its immediate neighbors located on its two opposite
sides. This difference is then amplified by cell-cell interactions
and positive feedback loops such that Wnt induces Vangl2
protein aggregation only on the proximal side of the limb bud
cell, laying the ground for further asymmetric cellular behavior.
This is consistent with regulation of PCP in the Drosophila wing
in which a Vang/ clone reorients Vang protein localization in
the surrounding wild-type cells to the side closer to the Vang/
clone through cell-cell interaction (Taylor et al., 1998; Figure 1 in
Bastock et al., 2003). Because the Wnt5a signaling gradient
determines that Vangl2 activity in the limb bud is the highest in
the distal and lowest in the proximal end, by analogy to the
Drosophila wing, the result of cell-cell interaction will cause
Vangl2 protein to be localized to the proximal side of chondro-
cytes. It is interesting to note that there is a P-D gradient of
Vangl2 asymmetrical localization (Figure 4B), suggesting that
distal chondrocytes are more polarized. Because Wnt5a also
signals through Ror2 and Vangl2 to inhibit the antichondrogenic
Wnt/b-catenin signaling, Wnt5a signaling is required for distal
limb chondrogenesis and cartilage elongation by coordinating
chondrocyte cell fate determination and cell polarity.
It is likely that in other places such as the frontonasal
processes, aWnt5a protein gradient also defines a unidirectional
polarity. In support of this, Wnt5a is expressed in a graded
fashion in the limb, branchial arches, and tail bud andWnt5a/,
Ror2/, and Vangl2Lp/Lp mutants showed similar defects in
cartilage elongation, craniofacial morphogenesis, and CEmove-
ment (DeChiara et al., 2000; Oishi et al., 2003; Yamaguchi et al.,
1999). In addition, a recent series of studies have shown that
while there are stage-specific variations, the theme underlying
different stages of limb bud initiation and elongation is that
mesoderm and cartilage cells in the limb bud have a distinct
polarity that drives oriented cell behaviors and that noncanonical
Wnt signaling, driven at least in part by the ligand Wnt5a, is
important to all stages of limb bud outgrowth (Boehm et al.,
2010; Wyngaarden et al., 2010; Gros et al., 2010). It is likely
that Wnt5a regulation of PCP is also important prior to cartilage
formation in the limb. As stabilization of PCP requires close cell-
cell contact, which is not possible or much weaker in the loose
limb mesenchymal cells before mesenchymal condensation to
form cartilage, asymmetrical Vangl2 localization was only
observed upon chondrocyte differentiation. Thus, defects in
craniofacial morphogenesis and cartilage elongation in Robinow
syndrome and BDB1 can be attributed to defects in PCP.Wnt5a
has also been found to be expressed in discrete patterns in the
developing cartilage and bone (Yang et al., 2003), it will be inter-
esting to further determine the function of PCP regulated by
Wnt5a in the later developing skeletal system. As many different
Wnts can act through Ror2 to induce Vangl2 phosphorylation,
controlling PCP is another fundamental role of vertebrate Wnts
in development. Lack of open neural tube and inner ear hairental Cell 20, 163–176, February 15, 2011 ª2011 Elsevier Inc. 171
Figure 6. Wnt-Induced Vangl2 Phosphorylation Is Required for Its Function
(A) CHO cells expressing wild-type or the indicated mutant Wnt5a were cocultured with Vangl2- and Ror2- expressing CHO cells at a ratio of 4:1.
(B) Ror2-BDB (W749X) and Ror2-RS (Q502X) mutants failed to enhance Wnt5a-induced Vangl2 phosphorylation in Ror2/MEFs. The kinase-dead Ror2 (Ror2-
KD) showed similar activity as the wild-type Ror2.
(C) Effects of Vangl2 Lp mutations (D255E and S464N) and the control S464A mutation on Vangl2 phosphorylation were analyzed by immunoblot in CHO
cells.
(D) Analysis of endogenous Vangl2 protein levels and phosphorylation by immunoblot in the brain of the Vangl2Lp/Lp embryo.
(E) Analysis of wild-type Vangl2 phosphorylation in CHO cells when co-expressed with the D255E or S464N Lp mutant Vangl2.
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Figure 7. Wnt5a Gradient Controls Pattern
Formation by Regulating Vangl2 Phosphor-
ylation in a Dose-Dependent Manner
(A) The E11.5 mouse limb bud was separated into
distal, middle, and proximal parts (schematics) for
immunoblot analysis of Vangl2 phosphorylation.
(B) Distal limb bud tissues of E11.5 wild-type,
Ror2/ and Wnt5a/ embryos, as shown by
the schematic diagram, were subject to immuno-
blot analysis using Vangl2 or phospho-specific
(pS82/84) Vangl2 antibodies. The Vangl2 in the
Ror2/ and Wnt5a/ mutant limb was shifted
to hypophosphorylated forms (lower arrows)
without altering S84 and S82 phosphorylation.
(C)Wnt5a-expressing CHO cells were cocultured
with CHO cells expressing Vangl2+Ror2 at
increasing ratio. The last boxed lane was extracts
fromWnt5a,Ror2, and Vangl2 cotransfected CHO
cells that showed the most robust induction of
Vangl2 phosphorylation.
(D) Recombinant Wnt5a proteins induced Vangl2
phosphorylation in a dose-dependent manner in
CHO cells after 2 hr treatment. Vangl2 phosphor-
ylation was saturated by 500 ng/ml of Wnt5a.
(E and F) A model of a Wnt5a gradient controlling
P-D limb elongation by providing a global direc-
tional cue. (E) Wnt5a induces Ror2 and Vangl2
complex formation and as a result, different
numbers of S and T residues of Vangl2 in the
two clusters were phosphorylated depending on
the Wnt5a dosages. (F) Wnt5a is expressed in
a gradient (orange) in the developing limb bud
and this Wnt5a gradient is translated into an
activity gradient of Vangl2 by inducing different
levels of Vangl2 phosphorylation (blue). The
Vangl2 activity gradient then induces asymmet-
rical Vangl2 localization (blue) and downstream
polarized events.
See also Figure S7.
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Wnt Controls PCP by Inducing Vangl Phosphorylationcell polarity defects in the Wnt5a/ embryos suggests that
Wnt5a’s function has been compensated by other Wnts. For
instance,Wnt11 can act as a directional cue to organize the elon-
gation of early muscle fibers through the PCP pathway (Gros
et al., 2009). In the limb, the nonredundant role of Wnt5a in(F) Wild-type, S84A, S517A::S7684A (all phospho mutant) or S5,82,84E (phosphomimicking) mouse V
zebrafish trim209/+ 3 trim209/+ matings at different doses. The phenotypes of injected zebrafish embryos
and D) as shown by the representative pictures.
(G) Statistical analysis of results of wild-type (a and d), S84A (b and e), S517A::S7684A (c and f), an
Numbers of injected zebrafish embryos of the indicated genotypes are indicated above the bars. The pe
A and B) was shown on the right of each panel.
(H) Analysis of Vangl2 proteins in the injected fish embryos. HA-tagged wild-type and mutant Vangl2 protei
mRNA in wild-type embryos were shown in left panel. Quantified results by densitometer were shown in
Error bars are ± SD, n = 3. See also Figure S6.
Developmental Cell 20, 163–176, Fcontrolling PCP is likely due to the fact
that Wnt5a expression is much stronger
than other Wnts and is the only Wnt that
is expressed in a gradient in the limb
mesenchyme along the P-D axis (Gavin
et al., 1990; Parr et al., 1993; Yamaguchi
et al., 1999) (Figure S4B).Interestingly, a recent study found that the ground polarity in
C. elegans is established by instructive Wnt/EGL-20 activity via
the Ror receptor tyrosine kinase CAM-1 and the planar cell
polarity component Van Gogh (Green et al., 2008), suggesting
that this pathway is evolutionarily conserved. In this regard, itangl2 mRNA was injected to offsprings from the
were classified into four groups (group A, B, C,
d S5,82,84E (g) mouse Vangl2 mRNA injection.
rcentage of rescued trim209/m209 emrbyos (Group
ns synthesized from different amounts of injected
the right panel.
ebruary 15, 2011 ª2011 Elsevier Inc. 173
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Wnt Controls PCP by Inducing Vangl Phosphorylationwill be important to test whether the Drosophila Ror2 ortholog
also plays a regulatory role in PCP. In addition, because CKI is
required to regulate Vangl2 phosphorylation and CKI is essential
in controlling PCP in Drosophila, it is likely that Vangl2 is a func-
tionally significant substrate of CKI.
We noticed that the phenotypes of Ror2/ and Vangl2/ are
not identical and the more severe Ror2/;Vangl2/ double
mutants phenocopied Wnt5a/ in the limb. Ror2 and Vangl2
must have roles independent of each other. It is also possible
that Frizzleds are other Wnt binding proteins in the Ror2/Vangl2
complex and the function of Ror2 might be to enhance or stabi-
lize Wnt binding to this complex. While Wnt5a has been shown
to play a permissive role in directional melanoma cell movement
by inducing the formation of a Frizzled-containing receptor-
actin-myosin intracellular structure (Witze et al., 2008), our
data argue strongly that in vivo Wnt5a plays an instructive role
to control cell polarity by inducing Vangl2 phosphorylation in
a dose-dependent manner. Understanding noncanonical Wnt
signal transduction has been hampered in the past by lacking
a robust and reliable immediate signaling readout. Identification
of Ror2 and Vangl2 as essential Wnt receptor components for
PCP and Wnt-induced Vangl2 phosphorylation have laid the
foundations for further understanding of Wnt/PCP signal
transduction.EXPERIMENTAL PROCEDURES
Mouse Lines and Genotyping
Ror2,Wnt5a, Topgal, and Vangl2mouse strains and their genotyping methods
have been described previously (DeChiara et al., 2000; Takeuchi et al., 2000;
Yamaguchi et al., 1999; Song et al., 2010; Topol et al., 2003; Kibar et al., 2001).Plasmids and Antibodies
Flag, Myc, or HA tag was added to C-terminal end of Ror2 or N-terminal end of
Vangl2 protein. YFP peptide was fused to N terminus of Vangl2 protein and
CFP peptide was fused to C terminus of Ror2 protein. All Vangl2 S or T to
A mutations, Loop tailmutations (D255E, S464N), kinase dead Ror2 mutations
(K507R, K510R, K512R), or Wnt5a mutations (C83S, C182R) were introduced
by site-directed mutagenesis. Phospho-specific Vangl2 antibodies (pS84,
pS82/84, and pS82+pS84) were generated by immunizing rabbits with respec-
tive phosphopeptide corresponding to amino acids 7694, and affinity puri-
fied sequentially through columns covalently coupled with phosphopeptides
and un-phosphopeptides. Other antibodies used in this study are described
in the Supplemental Experimental Procedures.Immunostaining and Confocal Microscopy
Embryos were fixed in 4%PFA for 30 min and subject to standard protocols of
cryosection and fluorescent immunohistochemistry. Wheat germ agglutinin
staining was performed following manufacture’s protocol (Invitrogen).
Confocal images were acquired by a Zeiss LSM 510 NLO Meta system. Pro-
jected Z-stack images were acquired at 0.2 mm intervals for 4mm8mm and
projected by Zeiss LSM 510 software.Luciferase Assay
Mouse embryonic fibroblasts (MEFs) were transfected with Super-TOPFLASH
(gift fromRandyMoon) andRenilla Luciferase plasmids (Promega) by Lipofect-
amine 2000 (Invitrogen). 0.5% FCS-contained control medium, Wnt3a or
Wnt5a conditioned medium from L Cells were added to the cells 24 hr after
transfection and incubated for 24 hr. Luciferase activity was measured on Lu-
mat LB9507 Luminometer (EG&G Berthold) according to the Dual Luciferase
Reporter Assay System Manual (Promega). The Super-TOPFLASH luciferase
activity was normalized to Renilla luciferase activity.174 Developmental Cell 20, 163–176, February 15, 2011 ª2011 ElsevImmunoprecipitation and Immunoblotting
In Co-IP experiment, transfected cells were lysed in lysis buffer (20 mM Tris-
HCl [pH 7.4], 150 mM NaCl, 0.5% Nonidet P-40) with protease inhibitors
cocktail (Roche) and phosphatase inhibitors (10 mM NaF, 20 mM b-glycero-
phosphate, 1 mM Na3VO4) and incubated with the indicated antibodies for
overnight at 4C followed by 2 hr incubation of Protein-G Plus (Santa Cruz)
at 4C. Immunoprecipitates were washed three times in lysis buffer, dissolved
in NuPAGE LDS sample buffer (Invitrogen), and subjected to standard western
immunoblot analysis.
Vangl2 Phosphorylation Assay
CHO cells (13 105) were seeded in 12-well plate for 24 hr before the cells were
transfected with Vangl2, Ror2, orWnt expression plasmids by using Lipofect-
amine 2000 (Invitrogen). After 48 hr, cells were lysed in the above lysis buffer
containing protease and phosphoatase inhibitors and proteins in the lysates
were separated by 10%Bis-Tris Gel for 4 hr at 130V. Vangl2 protein was exam-
ined by standard immunoblot analysis. In coculture experiments, Vangl2 and
Ror2-expressing and Wnt5a-expressing cells were trypsinized and mixed in
various ratios 16 hr after transfection and cultured for 32 hr before harvesting.
Wnt5a recombinant protein at indicated concentration was added into the
medium of Vangl2 and Ror2 -expressing cells 46 hr after transfection and
the cells were incubated for 2 hr before harvesting.
FRET Assay
YFP-Vangl2 or/and Ror2-CFP transfected MDCK cells growing on chambered
coverglass were examined under Zeiss LSM 510NLOMeta system. CFP, YFP,
and FRET Images were obtained from three channels, respectively, using
Zeiss AIM software. Sensitized Emission crosstalk coefficients were deter-
mined using control cells that expressed only YFP-Vangl2 or Ror2-CFP.
Multiple cells and regions were chosen, processed and calculated by LSM
FRET Tool Version 3.0. FRET efficiency was shown as N-FRET with intensities
converted from the FRET index calculated for each pixel using the Xia method.
Zebrafish Assay
mRNAs encoding wild-type or mutant mouse Vangl2 were synthesized using
the AmbionmMessagemMachine Kit following its instructions. Different doses
of mRNA were injected into offspring of trim209/+ zebrafish mating at 1 cell
stage. After 48 hr, all injected zebrafish were classified into four groups ac-
cording to phenotypes prior to genotyping. Genotyping method is described
in the Supplemental Experimental Procedures. For western blot analysis,
mRNAs were injected into wild-type zebrafish embryos at 1 cell stage. The
embryos were harvested and lysed after 24 hr.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and seven figures and can be found with this article online at doi:10.1016/j.
devcel.2011.01.001.
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